
Shenzhen Yilifang Biotechnology Co., Ltd. was established in 2013, dedicated to the development, production and sales of in vitro diagnostic reagents for precision medicine.
All employees of Yilifang work hard, cooperate and win-win with all sectors of society, and constantly surpass themselves.
Yilifang attaches great importance to the construction of its own research and development team in order to achieve long-term development goals and to have independent intellectual property rights in various technical fields.
Yilifang is a research and
development team composed of scientific researchers from top international
research institutions and domestic translation medicine elites. Been guided by
clinical needs, taking the existing "pain points" in the market, Yilifang
committed to creating good products that can solve the real needs of the market.
Details
Details
Details
Details
Details
Yilifang was established in the context of the new era of precision medicine. Since its establishment, it has been developing in a pragmatic and stable style of work, vigorously coordinated development in personnel training, research and innovation, safety compliance, quality system construction, etc. has also obtained preliminary achievements.
億立方與右江民族醫(yī)學(xué)院唐乾利教授科研團(tuán)隊(duì)共同抗疫,受到百色市政府和深圳坪山區(qū)政府的高度重視。3月23日,百色市常務(wù)副市長(zhǎng)石國(guó)懷親自率隊(duì)實(shí)地看望抗疫一線(xiàn)科研人員,坪山區(qū)委書(shū)記陶永欣、區(qū)長(zhǎng)李勇、副區(qū)長(zhǎng)陳華平等工作人員陪同來(lái)我司調(diào)研。調(diào)研期間各位領(lǐng)導(dǎo)聽(tīng)取了億立方國(guó)內(nèi)外抗疫工作匯報(bào),對(duì)取得的成績(jī)給予了肯定,并鼓勵(lì)團(tuán)隊(duì)成員再接再厲,為疫情阻擊戰(zhàn)的勝利提供力量。會(huì)上針對(duì)此次的科技合作,國(guó)懷常務(wù)副市長(zhǎng)、永欣書(shū)記、李勇區(qū)長(zhǎng)與億立方公司進(jìn)行深入探討,希望依托于坪山區(qū)所具備的生物產(chǎn)業(yè)優(yōu)勢(shì),通過(guò)一些當(dāng)?shù)仄髽I(yè)把先進(jìn)的醫(yī)療項(xiàng)目引入到百色市,讓科技的力量在百色市這片紅色的土壤中發(fā)芽壯大,從而推進(jìn)高科技產(chǎn)業(yè)落戶(hù)百色,幫助百色打贏疫情阻擊戰(zhàn)和扶貧攻堅(jiān)戰(zhàn)。
Details...
3月25日,廣東省委、省政府召開(kāi)廣東省科技創(chuàng)新大會(huì)深圳分會(huì)場(chǎng)會(huì)議,我司“甲型/乙型流感抗原檢測(cè)試劑盒(熒光免疫層析法)”項(xiàng)目榮獲科技進(jìn)步二等獎(jiǎng)。 “甲型/乙型流感抗原檢測(cè)試劑盒(熒光免疫層析法)”是我司的重點(diǎn)項(xiàng)目,是針對(duì)目前流感檢測(cè)方法不足的強(qiáng)有力補(bǔ)充,更是此次疫情期間區(qū)分新冠患者和流感患者的利器。此次獲獎(jiǎng)是億立方人長(zhǎng)期以來(lái)不懈努力的碩果,我們將珍惜榮譽(yù),再接再厲,繼續(xù)提高自主創(chuàng)新能力,提升科技成果轉(zhuǎn)化實(shí)效,推動(dòng)醫(yī)療事業(yè)發(fā)展,為人民健康作出力所能及的貢獻(xiàn)。
Details...
近日,深圳市億立方生物技術(shù)有限公司的“新型冠狀病毒COVID-19 IgG、IgM抗體檢測(cè)試劑盒(膠體金法)”、“新型冠狀病毒2019-nCoV核酸檢測(cè)試劑盒(PCR-熒光探針?lè)ǎ焙汀靶滦凸跔畈《綜OVID-19 IgG、IgM抗體檢測(cè)試劑盒(熒光免疫層析法)”三款新冠病毒檢測(cè)試劑獲得歐盟CE認(rèn)證,并都獲得醫(yī)療器械產(chǎn)品出口銷(xiāo)售證明。
Details...